Oestrogen Binding and Breast Cancer Risk Factors
Author Information
Author(s): D.M. Ingram, E.M. Nottage, D.L. Willcox, A. Roberts
Primary Institution: University Department of Surgery, Queen Elizabeth II Medical Centre
Hypothesis
Does oestrogen binding to serum proteins play a role in the development of breast cancer?
Conclusion
The study found limited evidence that oestrogen binding is associated with breast cancer risk factors.
Supporting Evidence
- Women with higher body mass had greater bioavailability of oestradiol.
- Changes in oestradiol binding were noted with age, particularly around menopause.
- Statistical significance was not reached for differences in oestradiol binding between cases and controls.
Takeaway
This study looked at how oestrogen in women's bodies might be linked to breast cancer, but it didn't find strong proof that it causes the disease.
Methodology
The study involved 518 women, including breast cancer patients and controls, who were assessed for oestrogen binding and various risk factors.
Potential Biases
Potential biases include selection bias in choosing controls and the influence of body mass on oestrogen levels.
Limitations
The study's findings may not be conclusive due to the complexity of the relationship between oestrogen binding and breast cancer.
Participant Demographics
The study included women with invasive breast cancer, benign epithelial hyperplasia, and fibrocystic disease, matched by age and area of residence.
Statistical Information
P-Value
0.0156 for free oestradiol, 0.0116 for albumin-bound oestradiol
Confidence Interval
95%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website